JMB-HEADER NAUKA RAS RAS-JOURNALS EIMB Pleiades Publishing

RUS

             

ENG

YearIMPACT-FACTOR
2017  0,977
2016  0,799
2015  0,662
2014  0,740
2013  0,739
2012  0,637
2011  0,658
2010  0,654
2009  0,570
2008  0,849
2007  0,805
2006  0,330
2005  0,435
2004  0,623
2003  0,567
2002  0,641
2001  0,490
2000  0,477
1999  0,762
1998  0,785
1997  0,507
1996  0,518
1995  0,502
Vol 52(2018) N 3 p. 335-349; DOI 10.1134/S0026893318030068 Full Text

O.I. Kiseleva*, A.V. Lisitsa, E.V. Poverennaya

Proteoforms: Methods of Analysis and Clinical Prospects

Orekhovich Institute of Biomedical Chemistry, Moscow, 119121 Russia

*olly.kiseleva@gmail.com
Received - 2017-07-04; Accepted - 2017-09-19

A critical analysis of proteomes provides a basis for understanding the operation of complex biochemical systems. A personalized approach to therapy takes into account biological uniqueness of each patient at genome, transcriptome, and proteome levels, and is a priority area in molecular medicine. The identification of proteoforms, which have dramatic impact on the phenotype of a disease, is a fundamental task of personal molecular profiling. Considerable progress of proteomic approaches presented new avenues for accurate, specific, and high-performance protein analysis. Thus, the identification of new efficient bio-markers can be expected based on studies of aberrant proteoforms associated with various diseases.

proteoforms, proteome heterogeneity, human proteome, biomarkers



JMB-FOOTER RAS-JOURNALS